B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SLC6A5

MOLECULAR TARGET

solute carrier family 6 member 5

UniProt: Q9Y345NCBI Gene: 91522 compounds

SLC6A5 (solute carrier family 6 member 5) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SLC6A5

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1arachidonoyl glycine2.7114
2Glycine0.691

About SLC6A5 as a Drug Target

SLC6A5 (solute carrier family 6 member 5) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented SLC6A5 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SLC6A5 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.